Literature DB >> 10581378

Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T(1), T(2) and MT histograms.

G Iannucci1, L Minicucci, M Rodegher, M P Sormani, G Comi, M Filippi.   

Abstract

The degree of disability and cerebellar and brainstem impairments in multiple sclerosis (MS) patients were correlated with several magnetic resonance imaging (MRI) measures of tissue damage in the whole brain, cerebellum and brainstem to determine the relative contributions of the factors underlying the development of disability in MS. Dual-echo conventional spin-echo, T(1)-weighted and magnetization transfer (MT) scans were obtained from 72 patients with MS and 20 age- and sex-matched controls. The following MRI-derived quantities were considered for the brain as a whole, for the cerebellum and for the brainstem: (a) the number and volume of lesions seen on T(2)-weighted images; (b) the number and volume of lesions seen on T(1)-weighted images; (c) the size of these structures measured on T(1)-weighted scans; (d) the average MT ratio (MTR), peak height and peak position for the MT histogram. With univariate analysis, many MRI measures were significantly different in patients with different levels of disability or cerebellar and brainstem functional system impairments. However, with multivariate analysis, only whole-brain average MTR was significantly related to physical disability, while cerebellar and brainstem T(1) lesion volume and average MTR were related to cerebellar and brainstem impairment. This study shows that increased pathological damage in clinically eloquent sites is the major cause of disability in patients with MS. It also suggests that measures derived from MT histogram analysis and T(1) hypointense lesion load should be considered when evaluating long-term MS evolution.

Entities:  

Mesh:

Year:  1999        PMID: 10581378     DOI: 10.1016/s0022-510x(99)00259-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

Review 1.  Clinical trials and clinical practice in multiple sclerosis: conventional and emerging magnetic resonance imaging technologies.

Authors:  Massimo Filippi; Maria A Rocca; Marco Rovaris
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

Review 2.  MRI in multiple sclerosis: what's inside the toolbox?

Authors:  Mohit Neema; James Stankiewicz; Ashish Arora; Zachary D Guss; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-10       Impact factor: 7.620

3.  Advanced magnetic resonance imaging techniques to better understand multiple sclerosis.

Authors:  Wafaa Zaaraoui; Bertrand Audoin; Jean Pelletier; Patrick J Cozzone; Jean-Philippe Ranjeva
Journal:  Biophys Rev       Date:  2010-04-02

Review 4.  MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.

Authors:  Massimo Filippi; Maria Assunta Rocca
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

5.  Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis.

Authors:  Allan J MacKenzie-Graham; Gilda A Rinek; Andrea Avedisian; Laurie B Morales; Elizabeth Umeda; Benoit Boulat; Russell E Jacobs; Arthur W Toga; Rhonda R Voskuhl
Journal:  J Neurosci Res       Date:  2012-03-13       Impact factor: 4.164

6.  Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis.

Authors:  Sreeram V Ramagopalan; Gabriele C Deluca; Katie M Morrison; Blanca M Herrera; David A Dyment; Matthew R Lincoln; Sarah-Michelle Orton; Michael J Chao; Alexandra Degenhardt; Maura Pugliatti; A Dessa Sadovnick; Stefano Sotgiu; George C Ebers
Journal:  J Neurol       Date:  2008-06-20       Impact factor: 4.849

7.  Bringing CLARITY to gray matter atrophy.

Authors:  Rory D Spence; Florian Kurth; Noriko Itoh; Chandler R L Mongerson; Shannon H Wailes; Mavis S Peng; Allan J MacKenzie-Graham
Journal:  Neuroimage       Date:  2014-07-16       Impact factor: 6.556

Review 8.  Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve.

Authors:  Massimo Filippi; Maria A Rocca
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

9.  Purkinje cell loss in experimental autoimmune encephalomyelitis.

Authors:  Allan MacKenzie-Graham; Seema K Tiwari-Woodruff; Gaurav Sharma; Cynthia Aguilar; Kieumai T Vo; Lauren V Strickland; Laurie Morales; Boma Fubara; Melanie Martin; Russell E Jacobs; G Allan Johnson; Arthur W Toga; Rhonda R Voskuhl
Journal:  Neuroimage       Date:  2009-07-06       Impact factor: 6.556

10.  Quantification of brain damage in cerebrotendinous xanthomatosis with magnetization transfer MR imaging.

Authors:  Matilde Inglese; Nicola De Stefano; Elisabetta Pagani; Maria T Dotti; Giancarlo Comi; Antonio Federico; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.